Bharat Biotech, which received emergency use approval for its coronavirus vaccine 'Covaxin' on Sunday from India's drug regulator, virtually addressed a press conference today.In the press conference, the chairman Dr Krishna Ella addressed several queries on row over the vaccine's approval when it was still under "clinical trial mode."To that, he said that its vaccine is safe and the company is conducting trials in more than 12 countries apart from India. “We are not a company without experience in vaccines.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.